These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16105058)

  • 1. Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study.
    Astrup AS; Tarnow L; Rossing P; Pietraszek L; Riis Hansen P; Parving HH
    Kidney Int; 2005 Sep; 68(3):1250-7. PubMed ID: 16105058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy.
    Hovind P; Tarnow L; Rossing P; Carstensen B; Parving HH
    Kidney Int; 2004 Sep; 66(3):1180-6. PubMed ID: 15327415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Astrup AS; Tarnow L; Rossing P; Hansen BV; Hilsted J; Parving HH
    Diabetes Care; 2006 Feb; 29(2):334-9. PubMed ID: 16443883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
    Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Tarnow L; Astrup AS; Parving HH
    Scand J Clin Lab Invest Suppl; 2005; 240():73-9. PubMed ID: 16112962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved prognosis of diabetic nephropathy in type 1 diabetes.
    Andrésdóttir G; Jensen ML; Carstensen B; Parving HH; Hovind P; Hansen TW; Rossing P
    Kidney Int; 2015 Feb; 87(2):417-26. PubMed ID: 24918158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.
    Rossing P; Hougaard P; Borch-Johnsen K; Parving HH
    BMJ; 1996 Sep; 313(7060):779-84. PubMed ID: 8842069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.
    Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabetes Care; 2010 Jul; 33(7):1567-72. PubMed ID: 20357380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study.
    Nakayama M; Sato T; Miyazaki M; Matsushima M; Sato H; Taguma Y; Ito S
    Hypertens Res; 2011 Oct; 34(10):1106-10. PubMed ID: 21796127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without Nephropathy.
    Hjortebjerg R; Tarnow L; Jorsal A; Parving HH; Rossing P; Bjerre M; Frystyk J
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3032-40. PubMed ID: 26046968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intensified antihypertensive treatment in diabetic nephropathy: mortality and morbidity results of a prospective controlled 10-year study.
    Trocha AK; Schmidtke C; Didjurgeit U; Mühlhauser I; Bender R; Berger M; Sawicki PT
    J Hypertens; 1999 Oct; 17(10):1497-503. PubMed ID: 10526912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy.
    Tofik R; Torffvit O; Rippe B; Bakoush O
    Diabetes Res Clin Pract; 2012 Jan; 95(1):139-44. PubMed ID: 22078636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.
    Jorsal A; Tarnow L; Lajer M; Ek J; Hansen T; Pedersen O; Parving HH
    Mol Genet Metab; 2008 Jul; 94(3):347-51. PubMed ID: 18467141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
    Astrup AS; Nielsen FS; Rossing P; Ali S; Kastrup J; Smidt UM; Parving HH
    J Hypertens; 2007 Dec; 25(12):2479-85. PubMed ID: 17984670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of hypertension and antihypertensive treatment on the course and prognosis of diabetic nephropathy.
    Parving HH
    J Hypertens Suppl; 1990 Dec; 8(7):S187-91. PubMed ID: 2095388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients.
    Lajer M; Tarnow L; Jorsal A; Parving HH
    Nephrol Dial Transplant; 2007 Nov; 22(11):3235-9. PubMed ID: 17567649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case-control study.
    Brunkhorst R; Lufft V; Dannenberg B; Kliem V; Tusch G; Pichlmayr R
    Transplantation; 2003 Jul; 76(1):115-9. PubMed ID: 12865796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow--up study.
    Astrup AS; Tarnow L; Christiansen M; Hansen PR; Parving HH; Rossing P
    Diabet Med; 2007 Dec; 24(12):1381-5. PubMed ID: 17971180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis in diabetic nephropathy.
    Parving HH; Hommel E
    BMJ; 1989 Jul; 299(6693):230-3. PubMed ID: 2504376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.